Powered by
-
VRTX Stock Chart
Historical VRTX Prices
Vertex Pharmaceuticals Stock Analysis
Rating: Hold
Total Grade: C
Analysis Breakdown
| VRTX Stock Grade: | C |
| Fundamental Grade: | C |
| Quantitative Grade: | C |
| VRTX Earnings | |
| Earnings Growth: | D |
| Earnings Momentum: | B |
| Earnings Surprises: | B |
| Analyst Earnings Revisions: | B |
| VRTX Financial Information | |
| Sales Growth: | F |
| Operating Margin Growth: | D |
| Cash Flow: | C |
| Return on Equity: | B |
Vertex Pharmaceuticals Stock: Weekly View
| This Week: | C |
|---|---|
| Last Week: | C |
| Two Weeks Ago: | C |
VRTX Stock predictions, Articles, and Vertex Pharmaceuticals News
- From InvestorPlace
- From the Web
-
10 Stocks That Are Screaming Buys Right Now - June 12, 2018
Even in these unstable times, there are still gems to be found. These 10 stocks share a "strong buy" analyst consensus rating from the Street and compelling growth drivers. Continue…
-
The 10 Fastest-Growing Stocks to Invest In Right Now - May 22, 2018
Put these fast-growing stocks on your radar, if not in your portfolio, as your best shot at overcoming the market's summertime blues. Continue…
-
7 Fast-Growing Stocks to Buy Today - May 8, 2018
Growth is on a different track now, and here are some great ideas for stocks to buy to ride the momentum. Continue…
-
10 Healthcare Stocks to Stave Off the Market Flu - April 6, 2018
One thing is certain, healthcare isn’t going away. Continue…
-
10 Triple-A Stocks for the Second Quarter - March 23, 2018
Here are stocks that will be undeterred by volatility. All 10 have momentum, earnings and sales on their side right now. Continue…
-
3 Stocks to Watch on Thursday: Mondelez International Inc (MDLZ), Paypal Holdings Inc (PYPL) and Vertex Pharmaceuticals Incorporated (VRTX) - February 1, 2018
Mondelez (MDLZ) beat earnings expectations, Paypal (PYPL) revenue grew 24% and Vertex Pharmaceuticals' (VRTX) adjusted income up 74%. Continue…
-
10 Top S&P 500 Stocks in 2017 - December 22, 2017
The big winners for 2017 range from dentistry to energy to tech, and the biggest tech winners are based far from Silicon Valley. Continue…
-
Vertex Pharmaceuticals (VRTX) a Buy on Healthy Sales Growth - December 11, 2017
Currently, Vertex Pharmaceuticals Inc (NASDAQ:VRTX) has a Buy using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing approach. This represents no change from the previous week and is the same ranking VRTX has had from Portfolio Grader for 4 months. Continue…
-
Vertex Pharmaceuticals’ (VRTX) Strong Quant Score Make it a Buy - December 4, 2017
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) is a member of the 350 company Biotechnology GICS industry group, which is a segment of the 782 company GICS Health Care sector. The market value of VRTX is $35.6 billion which falls in the top 10% of its industry group. The stock's current Portfolio Grader score places it 32 among the 350 companies in this industry group, positioning it among the leaders; in the top quartile of the sector with a ranking of 102 among the 782 companies in the sector, and number 591 in the nearly 5,000 company Portfolio Grader universe. Continue…
-
Vertex Pharmaceuticals (VRTX) a Buy on Solid Sales Growth - November 27, 2017
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) is ranked as a Buy using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. This represents no change from the previous week and is the same ranking VRTX has had from Portfolio Grader for 4 months. Continue…
